A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Carcinoma of the Uterine Cervix - Concepedia

Concepedia

Publication | Open Access

A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Carcinoma of the Uterine Cervix

DOI Full Paper Access

63

Citations

30

References

2015

Year

Charles A. Kunos, Wei Deng, Dawn Dawson, Jayanthi Lea, Kristine Zanotti, Heidi J. Gray, David Bender, Perry P. Guaglianone, Jori S. Carter, Kathleen N. Moore

International Journal of Gynecological Cancer

References

	Year	Citations

Page 1